Aldeyra Therapeutics, Inc. (ALDX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.75
Day's range
$5.3

Aldeyra Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
KNOLL CAPITAL MANAGEMENT, LLC 05/15/2026 5.48 M $9.25 M   0.00% 9.10%
BLACKROCK, INC. 05/13/2026 3.76 M $6.36 M   -2.24% 6.26%
AQR CAPITAL MANAGEMENT LLC 05/15/2026 2.83 M $4.78 M   130.65% 4.70%
05/15/2026 2.36 M $3.99 M   100.00% 3.93%
KINGDON CAPITAL MANAGEMENT, L.L.C. 05/15/2026 2.15 M $3.64 M   16.34% 3.58%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 1.50 M $2.53 M   -1.96% 2.49%
D. E. SHAW & CO., INC. 05/15/2026 1.40 M $2.37 M   -12.32% 2.33%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.25 M $2.12 M   6.93% 2.08%
STATE STREET CORP 05/15/2026 1.12 M $1.90 M   2.38% 1.87%
MILLENNIUM MANAGEMENT LLC 05/15/2026 995.24 K $1.68 M   2,158.89% 1.65%
JANE STREET GROUP, LLC 05/12/2026 968.89 K $1.64 M   218.87% 1.61%
ARDSLEY ADVISORY PARTNERS LP 05/15/2026 950.00 K $1.61 M   -34.48% 1.58%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 863.19 K $1.46 M   146.62% 1.43%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 858.29 K $1.45 M   -12.38% 1.43%
05/08/2026 807.78 K $1.37 M   100.00% 1.34%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2026 796.82 K $1.35 M   -17.75% 1.32%
PROPEL BIO MANAGEMENT, LLC 05/14/2026 730.61 K $1.23 M   100.00% 1.21%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 624.17 K $1.05 M   1.95% 1.04%
GOLDMAN SACHS GROUP INC 05/15/2026 543.15 K $917.92 K   77.67% 0.90%
UBS GROUP AG 05/05/2026 537.57 K $908.49 K   461.86% 0.89%
MORGAN STANLEY 05/15/2026 518.64 K $876.51 K   -21.06% 0.86%
NORTHERN TRUST CORP 05/14/2026 374.81 K $633.43 K   -1.21% 0.62%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 338.62 K $572.27 K   100.00% 0.56%
ARDSLEY ADVISORY PARTNERS LP 05/15/2026 300.00 K $507.00 K   500.00% 0.50%
HRT FINANCIAL LP 05/14/2026 286.44 K $484.00 K   100.00% 0.48%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 278.44 K $470.57 K   342.62% 0.46%
WOODSTOCK CORP 04/08/2026 266.76 K $450.82 K   0.00% 0.44%
IEQ CAPITAL, LLC 05/15/2026 266.52 K $450.42 K   84.83% 0.44%
CITADEL ADVISORS LLC 05/15/2026 266.34 K $450.12 K   100.00% 0.44%
GSA CAPITAL PARTNERS LLP 05/08/2026 247.19 K $418.00 K   155.06% 0.41%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 234.00 K $395.46 K   455.82% 0.39%
TWO SIGMA INVESTMENTS, LP 05/15/2026 223.54 K $377.78 K   -22.21% 0.37%
BANK OF AMERICA CORP /DE/ 05/18/2026 215.33 K $363.91 K   -47.48% 0.36%
WELLS FARGO & COMPANY/MN 05/11/2026 189.73 K $320.64 K   -48.19% 0.32%
INVESCO LTD. 05/12/2026 169.70 K $286.79 K   4.05% 0.28%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2026 167.60 K $283.25 K   81.41% 0.28%
CAPTION MANAGEMENT, LLC 05/15/2026 165.00 K $278.85 K   371.43% 0.27%
PALO ALTO INVESTORS LP 05/15/2026 155.71 K $263.15 K   -30.94% 0.26%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 148.96 K $251.75 K   -16.71% 0.25%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 139.03 K $234.96 K   -9.00% 0.23%
BANK OF NEW YORK MELLON CORP 05/05/2026 136.75 K $231.10 K   18.12% 0.23%
MARSHALL WACE, LLP 05/15/2026 129.69 K $219.18 K   100.00% 0.22%
CITADEL ADVISORS LLC 05/15/2026 123.90 K $209.39 K   -46.41% 0.21%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 109.90 K $185.73 K   -59.10% 0.18%
JANE STREET GROUP, LLC 05/12/2026 106.30 K $179.65 K   85.84% 0.18%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 95.86 K $162.01 K   -92.37% 0.16%
MARINER, LLC 05/13/2026 91.87 K $155.26 K   301.60% 0.15%
CWM, LLC 05/14/2026 91.62 K $154.84 K   111.58% 0.15%
FOX RUN MANAGEMENT, L.L.C. 05/12/2026 90.96 K $152.82 K   333.51% 0.15%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 87.08 K $147.16 K   2.53% 0.14%

Aldeyra Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 184 institutional investors and hedge funds held shares of Aldeyra Therapeutics Inc. The most heavily invested institutionals were:

Knoll Capital Management, LLC: 5.48 M

BlackRock, Inc.: 3.76 M

AQR CAPITAL MANAGEMENT LLC: 2.83 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 2.15 M

683 Capital Management, LLC: 1.5 M

D. E. Shaw & Co., Inc.: 1.4 M

62.02% of Aldeyra Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 43.33 M shares in the last 24 months. This purchase volume represents approximately $227.89 M in transactions.